AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14985866 — intervention group
Group type: COMPARATOR
Intervention: Conventional peritoneal equilibrium test
Number of subjects: 20
Study 11794148 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once daily, initiated postoperatively
Number of subjects: 1711
Study 11794148 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily, initiated preoperatively
Number of subjects: 1711
Study 9608824 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal administration of fenoterol
Number of subjects: 0
Study 9608824 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of beta2-agonists
Number of subjects: 0
Study 9608824 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent administration of small doses of beta2-agonists
Number of subjects: 0
Study 9356783 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 96
Study 9356783 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 96
Study 9356783 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 96
Study 9356783 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug treatment during washout)
Number of subjects: 96
Study 2626455 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 5 mg
Number of subjects: 0
Study 2626455 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 10 mg
Number of subjects: 0
Study 2626455 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 20 mg
Number of subjects: 0
Study 2626455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11545 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids and Salazopyrin treatment postoperatively for 33 weeks
Number of subjects: 84
Study 11545 — intervention group
Group type: COMPARATOR
Intervention: No medical treatment postoperatively
Number of subjects: 84
Study 31762471 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 120
Study 31762471 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 120
Study 31762471 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal Saline)
Number of subjects: 120
Study 30790211 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive audio-visual respiratory bio-feedback
Number of subjects: 16
Study 30790211 — intervention group
Group type: COMPARATOR
Intervention: No pre-sleep arousal manipulation (control)
Number of subjects: 16
Study 28453348 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic whirlpool
Number of subjects: 60
Study 28453348 — intervention group
Group type: COMPARATOR
Intervention: Moist hot pack treatment
Number of subjects: 60
Study 28453348 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study 26255475 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐shaped locking internal fixation
Number of subjects: 100
Study 26255475 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 100
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E + placebo
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium + placebo
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E + selenium
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + placebo
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized Follow-Up (CFU) study
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: CFU study
Number of subjects: 35533
Study 23064404 — intervention group
Group type: EXPERIMENTAL
Intervention: SELECT biorepository
Number of subjects: 35533
Study 21619383 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1305 (test dose 250 mg, evening dose 125 mg on day 1, maintenance dose 125 mg twice daily)
Number of subjects: 65
Study 21619383 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1305 (test dose 500 mg, placebo evening dose, maintenance dose 125 mg twice daily)
Number of subjects: 65
Study 21619383 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo test and maintenance dose)
Number of subjects: 65
Study 19345063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 41
Study 16720089 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-determination group training (GSD-GT) for 16 hours
Number of subjects: 50
Study 15152127 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sheath removal (group A)
Number of subjects: 267
Study 15152127 — intervention group
Group type: COMPARATOR
Intervention: Late sheath removal (group B)
Number of subjects: 267
Study 11069791 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised IPT (900 mg twice weekly for 6 months, Regimen A)
Number of subjects: 208
Study 11069791 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised IPT (900 mg twice weekly for 6 months, Regimen B)
Number of subjects: 208
Study 11069791 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised IPT (300 mg daily for 6 months, Regimen C)
Number of subjects: 208
Study 9713652 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily rhuIL-2 therapy
Number of subjects: 27
Study 9713652 — intervention group
Group type: COMPARATOR
Intervention: Pulse rhuIL-2 therapy
Number of subjects: 27
Study 9713652 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 27
Study 8347386 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly feedback with peer comparison
Number of subjects: 183
Study 8347386 — intervention group
Group type: COMPARATOR
Intervention: Feedback (general)
Number of subjects: 183
Study 8347386 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback (intensity correlation)
Number of subjects: 183
Study 3940334 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual stimulation
Number of subjects: 200
Study 3940334 — intervention group
Group type: COMPARATOR
Intervention: Heating pad
Number of subjects: 200
Study 3940334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 3940334 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast pump
Number of subjects: 200
Study 30157389 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab 1.5 mg/kg/week (group A)
Number of subjects: 152
Study 30157389 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab 3.0 mg/kg every 2 weeks (group B)
Number of subjects: 152
Study 30157389 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (group C)
Number of subjects: 152
Study 30157389 — intervention group
Group type: COMPARATOR
Intervention: Emicizumab prophylaxis vs previous factor VIII prophylaxis (intraindividual comparison)
Number of subjects: 152
Study 26964733 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa for 2 years
Number of subjects: 76
Study 26964733 — intervention group
Group type: COMPARATOR
Intervention: GH only
Number of subjects: 76
Study 24884563 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Dependency Scale (CDS) assessment at baseline, 6 months, and 12 months
Number of subjects: 890
Study 22648843 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiological and immunological enteral nutrition (probiotics, glutamine, fish oil)
Number of subjects: 67
Study 22648843 — intervention group
Group type: COMPARATOR
Intervention: Routine enteral nutrition
Number of subjects: 67
Study 19956970 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS)
Number of subjects: 8
Study 19956970 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8
Study 19956970 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS) in rats
Number of subjects: 8
Study 19102241 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic modes and reflex exposures in the complex therapy
Number of subjects: 484
Study 19102241 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal blocks
Number of subjects: 484
Study 19102241 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic modes and reflex exposures
Number of subjects: 484
Study 19102241 — intervention group
Group type: COMPARATOR
Intervention: Conventional complex therapy (control group)
Number of subjects: 484
Study 16078205 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (add-on therapy, starting dose of 500 mg twice per day up to 50 mg/kg/day)
Number of subjects: 16
Study 16078205 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 16
Study 11796385 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg
Number of subjects: 0
Study 11796385 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg
Number of subjects: 0
Study 11796385 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation
Number of subjects: 0
Study 10959316 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 744
Study 10959316 — intervention group
Group type: COMPARATOR
Intervention: Control (not treated with clozapine)
Number of subjects: 744
Study 7566945 — intervention group
Group type: EXPERIMENTAL
Intervention: Acenocoumarol treatment for at least 2 years (duration of treatment: 75.0 ± 52 months)
Number of subjects: 45
Study 7566945 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated by anticoagulant)
Number of subjects: 45
Study 2255215 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (Nicolan)
Number of subjects: 0
Study 2255215 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study 348615 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C, 0.8 mg/kg body weight intravenously, twice a week for 5 weeks after surgery
Number of subjects: 496
Study 348615 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 496
Study 31014975 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients identifying medications by name (brand name: 50%; generic: 21%)
Number of subjects: 768
Study 31014975 — intervention group
Group type: COMPARATOR
Intervention: Physicians' perception of patient identification
Number of subjects: 768
Study 31014975 — intervention group
Group type: COMPARATOR
Intervention: Pharmacists' perception of patient identification
Number of subjects: 768
Study 28341062 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-mastectomy radiation therapy (PMRT)
Number of subjects: 1649
Study 26144908 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide to Denosumab
Number of subjects: 94
Study 26144908 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab to Teriparatide
Number of subjects: 94
Study 26144908 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination to Denosumab
Number of subjects: 94
Study 23633195 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month combined aerobic and resistance exercise program
Number of subjects: 0
Study 21634303 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin supplementation (1 g/day for 6 weeks)
Number of subjects: 58
Study 21634303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 19162568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 40mg
Number of subjects: 3
Study 19162568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 80mg
Number of subjects: 3
Study 19162568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 160mg
Number of subjects: 3
Study 17272357 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/day clopidogrel
Number of subjects: 60
Study 17272357 — intervention group
Group type: COMPARATOR
Intervention: 75 mg/day clopidogrel
Number of subjects: 60
Study 15133336 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss Lithoclast (SLC)
Number of subjects: 38
Study 15133336 — intervention group
Group type: COMPARATOR
Intervention: Electrokinetic lithotripter (EKL)
Number of subjects: 38
Study 11742194 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (EAC)
Number of subjects: 446
Study 11742194 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (OAC)
Number of subjects: 446
Study 9580087 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (1 g/8 h)
Number of subjects: 93
Study 9580087 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g/8 h) plus Amikacin (15 mg/kg/day)
Number of subjects: 93
Study 8220197 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (back rub)
Number of subjects: 105
Study 8220197 — intervention group
Group type: COMPARATOR
Intervention: Back rub without therapeutic touch
Number of subjects: 105
Study 3315775 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ribavirin (800-1600 mg/day for 7 days)
Number of subjects: 38
Study 3315775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 28029069 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment
Number of subjects: 40
Study 28029069 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field
Number of subjects: 40
Study 28029069 — intervention group
Group type: COMPARATOR
Intervention: Both groups combined
Number of subjects: 40
Study 26059103 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of 70 mg/kg bovine surfactant within 30 minutes after birth
Number of subjects: 207
Study 26059103 — intervention group
Group type: COMPARATOR
Intervention: Early treatment with surfactant therapy for established RDS
Number of subjects: 207
Study 24332485 — intervention group
Group type: EXPERIMENTAL
Intervention: Field-in-field (FIF) technique
Number of subjects: 89
Study 24332485 — intervention group
Group type: COMPARATOR
Intervention: Wedged beams (WB) technique
Number of subjects: 89
Study 24332485 — intervention group
Group type: COMPARATOR
Intervention: Comparison of FIF and WB techniques
Number of subjects: 89
Study 24032191 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture therapy
Number of subjects: 30
Study 20447648 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-centered dietary program (Diet)
Number of subjects: 165
Study 20447648 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-centered physical activity program (Activity)
Number of subjects: 165
Study 20447648 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both (Diet + Activity)
Number of subjects: 165
Study 20447648 — intervention group
Group type: COMPARATOR
Intervention: Activity (Control)
Number of subjects: 165
Study 19068673 — intervention group
Group type: EXPERIMENTAL
Intervention: Securebox
Number of subjects: 800
Study 19068673 — intervention group
Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 800
Study 15856507 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse reflectance spectroscopy
Number of subjects: 242
Study 15856507 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected autofluorescence spectroscopy
Number of subjects: 242
Study 15856507 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw autofluorescence spectroscopy
Number of subjects: 242
Study 15856507 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined autofluorescence and diffuse reflectance spectroscopy
Number of subjects: 242
Study 12531912 — intervention group
Group type: EXPERIMENTAL
Intervention: He-O2 breathing
Number of subjects: 12
Study 12531912 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspired CO2 breathing
Number of subjects: 12
Study 12531912 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 12
Study 10377079 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stent placement
Number of subjects: 254
Study 10377079 — intervention group
Group type: COMPARATOR
Intervention: Primary angioplasty followed by selective stent placement
Number of subjects: 254
Study 8670314 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 (10 mg/kg)
Number of subjects: 14
Study 8670314 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 (20 mg/kg)
Number of subjects: 14
Study 8670314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2070884 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeder vessel photocoagulation
Number of subjects: 0
Study 2070884 — intervention group
Group type: EXPERIMENTAL
Intervention: Scatter photocoagulation
Number of subjects: 0
Study 2070884 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 degrees of peripheral circumferential treatment
Number of subjects: 0
Study 2070884 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeder vessel treatment
Number of subjects: 0
Study 6418191 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 micrograms kg‐1
Number of subjects: 100
Study 6418191 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 8, 12 or 16 micrograms kg‐1
Number of subjects: 100
Study 6418191 — intervention group
Group type: COMPARATOR
Intervention: No analgesic supplementation
Number of subjects: 100
Study 6418191 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and Alfentanil (all doses)
Number of subjects: 100
Study 6418191 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (larger doses)
Number of subjects: 100
Study 31408343 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiconfiguration Time‐Dependent Hartree method using two potential surfaces for calculations.
Number of subjects: 0
Study 31408343 — intervention group
Group type: COMPARATOR
Intervention: Two potential energy surfaces used in calculations.
Number of subjects: 0
Study 31408343 — intervention group
Group type: COMPARATOR
Intervention: Theoretical approach compared with experimental observations.
Number of subjects: 0
Study 28434475 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention (30 minutes)
Number of subjects: 100
Study 28434475 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 100
Study 25791092 — intervention group
Group type: EXPERIMENTAL
Intervention: Packer's composite score
Number of subjects: 0
Study 25791092 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Journey score
Number of subjects: 0
Study 25791092 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐HeFT composite score
Number of subjects: 0
Study 23296186 — intervention group
Group type: EXPERIMENTAL
Intervention: dextroamphetamine (dAMPH) infusion (0.3mg/kg)
Number of subjects: 12
Study 23296186 — intervention group
Group type: EXPERIMENTAL
Intervention: baseline dopamine D2/3 receptor availability with [(123)I]IBZM SPECT
Number of subjects: 12
Study 21788428 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 μg LPS/kg BW (L75)
Number of subjects: 30
Study 21788428 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.50 μg LPS/kg BW (L150)
Number of subjects: 30
Study 21788428 — intervention group
Group type: COMPARATOR
Intervention: Control (0 μg LPS/kg BW)
Number of subjects: 30
Study 21788428 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (0.75 μg and 1.50 μg)
Number of subjects: 30
Study 21788428 — intervention group
Group type: EXPERIMENTAL
Intervention: High-CP diet
Number of subjects: 30
Study 19602473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) targeted therapy
Number of subjects: 48
Study 16696859 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha-2b and ribavirin (48 weeks treatment)
Number of subjects: 152
Study 15548142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (ASA) 0.5 mg/kg/day
Number of subjects: 90
Study 15548142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 11512248 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal photographs analyzed at 100 x magnification
Number of subjects: 12
Study 9415369 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrounding each word with digits or Greek letters
Number of subjects: 0
Study 9415369 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrounding each word with randomly chosen letters, while preserving spaces
Number of subjects: 0
Study 9415369 — intervention group
Group type: EXPERIMENTAL
Intervention: Removing spaces from text with Latin-letter fillers
Number of subjects: 0
Study 9415369 — intervention group
Group type: EXPERIMENTAL
Intervention: Filler types (Latin letters, Greek letters, digits, shaded boxes)
Number of subjects: 0
Study 7706601 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP and cholesterol enriched formula
Number of subjects: 59
Study 7706601 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula
Number of subjects: 59
Study 7706601 — intervention group
Group type: COMPARATOR
Intervention: Breastfed infants
Number of subjects: 59
Study 3300276 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT)
Number of subjects: 90
Study 3300276 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT) plus liver directed radiotherapy (RT)
Number of subjects: 90
Study 3300276 — intervention group
Group type: COMPARATOR
Intervention: Less than full RT doses
Number of subjects: 90
Study 28272294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse/physician interdisciplinary team training in a simulation center
Number of subjects: 0
Study 31885755 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion combined with methotrexate or leflunomide
Number of subjects: 46
Study 31885755 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate or leflunomide (Control)
Number of subjects: 46
Study 26951335 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 22
Study 26951335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 25527400 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification (ABM)
Number of subjects: 0
Study 25527400 — intervention group
Group type: COMPARATOR
Intervention: Placebo task (Control)
Number of subjects: 0
Study 23179507 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural play therapy (not performed)
Number of subjects: 30
Study 23179507 — intervention group
Group type: COMPARATOR
Intervention: Sham play therapy
Number of subjects: 30
Study 21531091 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 70
Study 21531091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70